ADIPOQ 抗体 (AA 108-244)
-
- 抗原 See all ADIPOQ 抗体
- ADIPOQ (Adiponectin (ADIPOQ))
-
抗原表位
- AA 108-244
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This ADIPOQ antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
- 原理
- Polyclonal Antibody to Adiponectin (ADPN)
- 特异性
- The antibody is a rabbit polyclonal antibody raised against ADPN. It has been selected for its ability to recognize ADPN in immunohistochemical staining and western blotting.
- 纯化方法
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
- 免疫原
- Recombinant Adiponectin (ADPN) corresdonding to Ala108~Asn244 with N-terminal His Tag
- 亚型
- IgG
- Top Product
- Discover our top product ADIPOQ Primary Antibody
-
anti-Adiponectin (ADIPOQ) (AA 151-244) antibody
ADIPOQ 适用: 人, 小鼠, 大鼠, Cow, Pig WB, ELISA, IHC (p), IHC (fro), IF (cc), IF (p) 宿主: 兔 Polyclonal unconjugated
anti-Adiponectin (ADIPOQ) (AA 111-244) antibodyADIPOQ 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Adiponectin (ADIPOQ) (AA 18-244) antibodyADIPOQ 适用: 犬 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Adiponectin (ADIPOQ) (AA 19-244) antibodyADIPOQ 适用: 小鼠, 大鼠 WB, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Adiponectin (ADIPOQ) (AA 111-244) antibodyADIPOQ 适用: 大鼠 WB, IHC, IP, ICC 宿主: 小鼠 Monoclonal C6 unconjugated
anti-Adiponectin (ADIPOQ) (AA 17-243) antibodyADIPOQ 适用: Pig WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Adiponectin (ADIPOQ) (AA 145-226) antibodyADIPOQ 适用: 人 WB, IHC, StM 宿主: 小鼠 Monoclonal ADPN-1370 unconjugated
anti-Adiponectin (ADIPOQ) (AA 16-154) antibodyADIPOQ 适用: 人 WB, ELISA, IHC, ICC, FACS 宿主: 小鼠 Monoclonal 3A12D5 unconjugated
anti-Adiponectin (ADIPOQ) (AA 16-154) antibodyADIPOQ 适用: 人 WB, ELISA, IHC, ICC, FACS 宿主: 小鼠 Monoclonal 1E10D5 unconjugated
anti-Adiponectin (ADIPOQ) (AA 19-244) antibodyADIPOQ 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
-
Western blotting: 0.5-2 μg/mL Immunohistochemistry: 5-20 μg/mL Immunocytochemistry: 5-20 μg/mL Optimal working dilutions must be determined by end user.
- 说明
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 储存方法
- Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
- 有效期
- 24 months
-
- 抗原
- ADIPOQ (Adiponectin (ADIPOQ))
- 别名
- Adiponectin (ADIPOQ 产品)
- 别名
- ADP antibody, DCAF9 antibody, 6720489L24Rik antibody, 9330209L04Rik antibody, Adp antibody, Mamdc1 antibody, RNSVSP4U antibody, SVSIV1 antibody, Svp4 antibody, ACDC antibody, ACRP30 antibody, ADIPQTL1 antibody, ADPN antibody, APM-1 antibody, APM1 antibody, GBP28 antibody, apM-1 antibody, 30kDa antibody, APN antibody, Acdc antibody, Acrp30 antibody, Ad antibody, adipo antibody, apM1 antibody, ADN antibody, acrpl antibody, adipo-b antibody, adipoql antibody, zgc:153584 antibody, adipoq antibody, WD and tetratricopeptide repeats 1 antibody, MAM domain containing glycosylphosphatidylinositol anchor 2 antibody, seminal vesicle secretory protein 4 antibody, adiponectin, C1Q and collagen domain containing antibody, adiponectin, C1Q and collagen domain containing, b antibody, adiponectin, C1Q and collagen domain containing L homeolog antibody, WDTC1 antibody, Mdga2 antibody, Svs4 antibody, ADIPOQ antibody, Adipoq antibody, adipoqb antibody, adipoq.L antibody
- 背景
- GBP28, ApM1, AdipoQ, Acrp30, ACDC, APM1, C1Q And Collagen Domain Containing, Adipocyte Complement-Related Protein Of 30 KDa, Adipose Most Abundant Gene Transcript 1
-
